An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

NCT00402103 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

556

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Aliskiren
DRUG: Amlodipine
DRUG: Hydrochlorothiazide

Sponsor

Novartis